D-0629-2021 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0629-2021 was initiated by Dr. Reddy's Laboratories, Inc. on June 4, 2021 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities The recall status is terminated (terminated February 16, 2023). Affected quantity: 5984 bottles.

Recall Details

Product Type
Drugs
Report Date
June 23, 2021
Initiation Date
June 4, 2021
Termination Date
February 16, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5984 bottles

Product Description

Atorvastatin Calcium Tablets, USP 10 mg, 500-count bottles, Rx Only, Dr. Reddy's Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, 500-090 India, NDC 55111-121-05.

Reason for Recall

Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: C905064, C905065, Exp. Date 07/2021